Skip to main content
SpringerLink
Log in

Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A boy affected by severe obesity (kg 117, Body Mass Index 37 kg/m2) and acanthosis nigricans, was treated with octreotide for 150 days (50 μg × three daily subcutaneous administrations). Before treatment the patient showed an exaggerated insulin (IRI) and C-peptide (CPR) response to a standard meal with a lowering in after-meal CPR/IRI molar ratio. During octreotide treatment both IRI and CPR response was reduced but CPR/IRI molar ratio rised after meal indicating an increase in hepatic insulin removal. Body weight and acanthosis nigricans were sharply reduced during treatment and the reduction was still maintained six months after the cessation of therapy. Furthermore, IRI and CPR response, as well as the behaviour of CPR/IRI molar ratio, remained within normal range. In conclusion long-term octreotide treatment has been able to correct hyperinsulinemia and to reduce body weight and acanthosis nigricans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Olefsky J.M., Kolterman O.G. Mechanism of insulin resistance in obesity and in non-insulin dependent (type II) diabetes. Am. J. Med. 74: 1238, 1984.

    Google Scholar 

  2. Stuart C.A., Pate C.J., Peters E.J. Prevalence of acanthosis nigricans in an unselected population. Am. J. Med. 87: 269, 1989.

    Article  CAS  PubMed  Google Scholar 

  3. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A. Characterization of group of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65: 499, 1987.

    Article  CAS  PubMed  Google Scholar 

  4. Flier J.S., Eastman R.C., Minaker K.L., Matteson D., Rowe J.R. Acanthosis nicricans in obese women with hyperandrogenism. Diabetes 34: 101, 1985.

    Article  CAS  PubMed  Google Scholar 

  5. Peters E.J., Stuart C.A., Prince M.J. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. Metabolism 35: 807, 1986.

    Article  CAS  PubMed  Google Scholar 

  6. Cruz P.D., Hud J.A. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J. Invest. Dermatol. 98: 82, 1992.

    Article  Google Scholar 

  7. Gavin J.R. III, Roth J., Neville D.M.J.R., De Meyts P., Buell D.N. Insulin-dependent regulation of insulin receptor concentration: a direct demonstration in cell culture. Proc. Natl. Acad. Sci. USA 71: 84, 1974.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Bar R.S., Gordon P., Roth J., Kahn C.R., De Meyts P. Fluctuation in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding and dieting. J Clin. Invest. 58: 1123, 1976.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Rodin J. Insulin levels, hunger, and food intake: an example of feedback loops in body-weight regulation. Health Psychol. 4: 1, 1985.

    Article  CAS  PubMed  Google Scholar 

  10. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T.J., Pless J. SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31: 1133, 1982.

    Article  CAS  PubMed  Google Scholar 

  11. Flier J.S., Usher P., Moses A.C. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblast. Proc. Natl. Acad. Sci. USA 83: 664, 1986.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Conover C.A., Hintz R.L., Rosenfeld R.G. Comparative effects of somatomedin C and insulin on the metabolism and growth of cultured human fibrobla. J. Cell. Physiol. 122: 133, 1985.

    Article  CAS  PubMed  Google Scholar 

  13. Verrando P., Ortonne J.P. Insulin receptors in cultured human keratinocytes. Br. J. Dermatol. (III, Suppl. 27): 232, 1984.

  14. Mirsa P., Nickoloff B.J., Morhenn V.B., Hintz R.L., Rosenfeld R.G. Characterization of insulin-like growth factor-I/somatomedin C receptors on human keratinocyte monolayers. J. Invest. Dermatol. 87: 264, 1986.

    Article  Google Scholar 

  15. Verrando P., Ortonne J.P. Insulin binding properties of normal and transformed human epidermal cultured keratinocyte. J. Invest. Dermatol. 85: 328, 1985.

    Article  CAS  PubMed  Google Scholar 

  16. Fradkin J.E., Eastman R.C., Lesniak M.A., Roth J. Specificity spillover at the hormone receptor-exploring its role in human disease. N. Engl. J. Med. 320: 640, 1989.

    Article  CAS  PubMed  Google Scholar 

  17. Field J. Extraction of insulin by the liver. Ann. Rev. Med. 24: 309, 1973.

    Article  CAS  PubMed  Google Scholar 

  18. Horwitz D., Star J., Marks M., Blankard W., Rubestein A. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J. Clin. Invest. 55: 1278, 1975.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Giustina A., Bussi A.R., Pizzocolo G., Cimino A., Giustina G. Acute effects of octreotide, a long-acting somatostatin analog, on the insulinemic and glycemic responses to a mixed meal in patients with essential obesity. A dose-response study. Diab. Nutr. Metab. 7: 35, 1994.

    Google Scholar 

  20. Wahren J., Eriksson L.S The influence of a long-acting somatostatin analogue on splanchnic haemodinamics and metabolism in healthy subjects and patients with liver cirrhosis. Scand. J. Gastroenterol. 21(Suppl. 119): 103, 1986.

    Article  Google Scholar 

  21. Barnes A.J., Long R.G., Adrian T.E. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin. Sci. 61: 653, 1981.

    CAS  PubMed  Google Scholar 

  22. Johansson C., Wisen O., Efendic S., Uvnas-Wallesten K. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22: 126, 1981.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Endocrinology and Metabolic Diseases, University of Catania, Catania, Italy

    M. Lunetta, M. Di Mauro & R. Le Moli

  2. Department of Medicine, Hospital Paternò Arezzo, Ragusa, Italy

    S. Burrafato

Authors
  1. M. Lunetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Di Mauro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Le Moli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Burrafato
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lunetta, M., Di Mauro, M., Le Moli, R. et al. Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans. J Endocrinol Invest 19, 699–703 (1996). https://doi.org/10.1007/BF03349042

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349042

Keywords

Search

Navigation